Ticker Details
Harmony Biosciences Holdings, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.77 | 2.09%
Avg Daily Range (30 D):	$0.77 | 2.19%
Avg Daily Range (90 D):	$0.61 | 1.76%

Institutional Daily Volume
Avg Daily Volume:	.44M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	.7M

Trade Size
Avg Trade Size (Sh.):	52
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	2,103
Avg Institutional Trade:	$2.36M
Avg Institutional Trade (30 D):	$2.64M
Avg Institutional Trade (90 D):	$2.95M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.98M
Avg Closing Trade (30 D):	$3.36M
Avg Closing Trade (90 D):	$4.09M
Avg Closing Volume:	82.71K

News

Feb 1, 2026 @ 3:19 AM Harmony Biosciences' CFO Sells All of Her Insider ... Source: Adé Hennis

Jan 27, 2026 @ 5:02 PM Harmony Biosciences' Sales and Profits Have Soared... Source: Dan Caplinger

Apr 8, 2025 @ 5:00 PM Developmental and Epileptic Encephalopathies Marke... Source: Delveinsight

Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight

Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$3.23	$.88	$.69
Diluted EPS	$3.17	$.87	$.68
Revenue	$825.94M	$239.46M	$200.49M
Gross Profit	$641.74M	$179.81M	$162.34M
Net Income / Loss	$185.68M	$50.87M	$39.78M
Operating Income / Loss	$225.64M	$65.49M	$48.18M
Cost of Revenue	$184.21M	$59.65M	$38.15M
Net Cash Flow	$259.63M	$100.95M	$57.05M
PE Ratio	8.90